B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ribavirin ADME

REACTOME PATHWAY
Reactome: R-HSA-97550886 genes16 compounds

The Ribavirin ADME pathway (Reactome ID: R-HSA-9755088) involves 6 genes and is affected by 16 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ADAADKPNPSLC28A2SLC28A3SLC29A1

Compounds Affecting Ribavirin ADME

#CompoundTargets HitStudies
1Adenosine298
2Uridine300
3dilazep300
4lidoflazine278
5Ticagrelor299
6Sirolimus300
7Fidaxomicin295
8Gemcitabine300
9Papaverine299
10Rifaximin298
11Toyocamycin 4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is210
12Afatinib297
13Tubercidin300
14Pentostatin297
15Coformycin171
16guanine299

About the Ribavirin ADME Pathway

The Ribavirin ADME pathway is catalogued in Reactome (ID: R-HSA-9755088) and involves 6 genes. In the BiohacksAI corpus, 16 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ADA, ADK, PNP, SLC28A2, SLC28A3.